UBS analyst Kevin Caliendo lowered the firm’s price target on Dentsply Sirona (XRAY) to $16 from $17 and keeps a Buy rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XRAY:
- Jefferies EU medical tech analyst holds analyst/industry conference call
- Dentsply Sirona price target raised to $14 from $13 at Mizuho
- Dentsply Sirona Renews Patterson Dental Technology Distribution Deal
- Dentsply Sirona, Patterson Dental renew U.S. dental distribution partnership
- Dentsply Sirona, Benco Dental expand partnership